1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22435
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSokka, T.en
dc.contributor.authorKautiainen, H.en
dc.contributor.authorPincus, T.en
dc.contributor.authorToloza, S.en
dc.contributor.authorda Rocha Castelar Pinheiro, G.en
dc.contributor.authorLazovskis, J.en
dc.contributor.authorHetland, M. L.en
dc.contributor.authorPeets, T.en
dc.contributor.authorImmonen, K.en
dc.contributor.authorMaillefert, J. F.en
dc.contributor.authorDrosos, A. A.en
dc.contributor.authorAlten, R.en
dc.contributor.authorPohl, C.en
dc.contributor.authorRojkovich, B.en
dc.contributor.authorBresnihan, B.en
dc.contributor.authorMinnock, P.en
dc.contributor.authorCazzato, M.en
dc.contributor.authorBombardieri, S.en
dc.contributor.authorRexhepi, S.en
dc.contributor.authorRexhepi, M.en
dc.contributor.authorAndersone, D.en
dc.contributor.authorStropuviene, S.en
dc.contributor.authorHuisman, M.en
dc.contributor.authorSierakowski, S.en
dc.contributor.authorKarateev, D.en
dc.contributor.authorSkakic, V.en
dc.contributor.authorNaranjo, A.en
dc.contributor.authorBaecklund, E.en
dc.contributor.authorHenrohn, D.en
dc.contributor.authorGogus, F.en
dc.contributor.authorBadsha, H.en
dc.contributor.authorMofti, A.en
dc.contributor.authorTaylor, P.en
dc.contributor.authorMcClinton, C.en
dc.contributor.authorYazici, Y.en
dc.date.accessioned2015-11-24T19:24:12Z-
dc.date.available2015-11-24T19:24:12Z-
dc.identifier.issn1468-2060-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22435-
dc.rightsDefault Licence-
dc.subjectAntirheumatic Agents/therapeutic useen
dc.subjectArthritis, Rheumatoid/diagnosis/drug therapy/*epidemiologyen
dc.subjectCost of Illnessen
dc.subjectEpidemiologic Methodsen
dc.subjectFemaleen
dc.subject*Health Status Disparitiesen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectSocioeconomic Factorsen
dc.subject*World Healthen
dc.titleDisparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA databaseen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1136/ard.2009.109983-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/19643759-
heal.identifier.secondaryhttp://ard.bmj.com/content/68/11/1666.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2009-
heal.abstractOBJECTIVE: To analyse associations between the clinical status of patients with rheumatoid arthritis (RA) and the gross domestic product (GDP) of their resident country. METHODS: The Quantitative Standard Monitoring of Patients with Rheumatoid Arthritis (QUEST-RA) cohort includes clinical and questionnaire data from 6004 patients who were seen in usual care at 70 rheumatology clinics in 25 countries as of April 2008, including 18 European countries. Demographic variables, clinical characteristics, RA disease activity measures, including the disease activity score in 28 joints (DAS28), and treatment-related variables were analysed according to GDP per capita, including 14 "high GDP" countries with GDP per capita greater than US$24,000 and 11 "low GDP" countries with GDP per capita less than US$11,000. RESULTS: Disease activity DAS28 ranged between 3.1 and 6.0 among the 25 countries and was significantly associated with GDP (r = -0.78, 95% CI -0.56 to -0.90, r(2) = 61%). Disease activity levels differed substantially between "high GDP" and "low GDP" countries at much greater levels than according to whether patients were currently taking or not taking methotrexate, prednisone and/or biological agents. CONCLUSIONS: The clinical status of patients with RA was correlated significantly with GDP among 25 mostly European countries according to all disease measures, associated only modestly with the current use of antirheumatic medications. The burden of arthritis appears substantially greater in "low GDP" than in "high GDP" countries. These findings may alert healthcare professionals and designers of health policy towards improving the clinical status of patients with RA in all countries.en
heal.journalNameAnn Rheum Disen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Sokka-2009-Disparities in rheum.pdf373.73 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons